Peel Hunt restated their hold rating on shares of Spire Healthcare Group (LON:SPI) in a report published on Thursday morning, ThisIsMoney.Co.Uk reports.
SPI has been the subject of several other reports. UBS Group started coverage on Spire Healthcare Group in a report on Tuesday, July 2nd. They set a neutral rating and a GBX 120 ($1.57) price target for the company. Barclays reaffirmed an underweight rating and set a GBX 115 ($1.50) price target on shares of Spire Healthcare Group in a report on Friday, May 10th. Numis Securities reaffirmed a buy rating and set a GBX 163 ($2.13) price target (down from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a report on Thursday, May 16th. Finally, Liberum Capital reaffirmed a hold rating on shares of Spire Healthcare Group in a report on Thursday, July 11th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company’s stock. Spire Healthcare Group presently has a consensus rating of Hold and an average price target of GBX 127.78 ($1.67).
Shares of LON SPI opened at GBX 104.10 ($1.36) on Thursday. The company has a current ratio of 1.44, a quick ratio of 0.95 and a debt-to-equity ratio of 48.52. The business’s fifty day moving average is GBX 116.93. Spire Healthcare Group has a 1-year low of GBX 96.15 ($1.26) and a 1-year high of GBX 248.80 ($3.25). The firm has a market capitalization of $417.53 million and a P/E ratio of 37.18.
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.